Skip to main content
ArticleOPEN ACCESS

Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: Is it time for additional evidence?

World Journal of Surgical Oncology
DOI: 10.1186/1477-7819-9-41
0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved. © 2011 Cafarotti et al; licensee BioMed Central Ltd.

References Powered by Scopus

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781

Journal of Clinical Oncology
1224Citations
N/AReaders
Get full text

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial

Lancet Oncology
885Citations
N/AReaders
Get full text

Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer

Cancer
31Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cafarotti, S., Cesario, A., Porziella, V., Margaritora, S., & Granone, P. (2011, April 19). Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: Is it time for additional evidence? World Journal of Surgical Oncology. https://doi.org/10.1186/1477-7819-9-41

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

40%

Researcher 2

40%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

83%

Sports and Recreations 1

17%

Save time finding and organizing research with Mendeley

Sign up for free